Vanda Pharmaceuticals Inc. v. MSN Pharmaceuticals Inc. et al > Summary

Court Case Number 1:24-cv-00815

Filing Date Jul 12, 2024

Court Delaware District Court

Status Unknown

Doc No	Title	Issue date
12201604	Treatment of circadian rhythm disorders	Jan 21, 2025
11918556	Treatment of circadian rhythm disorders	Mar 5, 2024
11918557	Treatment of circadian rhythm disorders	Mar 5, 2024
11850229	Treatment of circadian rhythm disorders	Dec 26, 2023
11833130	Treatment of circadian rhythm disorders	Dec 5, 2023
11826339	Treatment of circadian rhythm disorders	Nov 28, 2023
11786502	Method of treatment	Oct 17, 2023
11759446	Liquid tasimelteon formulations and methods of use thereof	Sep 19, 2023
11760740	Highly purified pharmaceutical grade tasimelteon	Sep 19, 2023
11566011	Highly purified pharmaceutical grade tasimelteon	Jan 31, 2023
11285129	Treatment of circadian rhythm disorders	Mar 29, 2022
11266622	Method of treatment	Mar 8, 2022
11141400	Method of treatment	Oct 12, 2021
10980770	Treatment of circadian rhythm disorders	Apr 20, 2021
10610510	Treatment of circadian rhythm disorders	Apr 7, 2020
10179119	Method of treatment	Jan 15, 2019
10149829	Treatment of circadian rhythm disorders	Dec 11, 2018
10071977	Highly purifid pharmaceutical grade tasimelteon	Sep 11, 2018
09730910	Treatment of circadian rhythm disorders	Aug 15, 2017
09539234	Treatment of circadian rhythm disorders	Jan 10, 2017